CCL2 and COVID-19: Elevated levels of TNF-α, CXCL10, CCL2, and IL-10 in COVID-19 patients correlate with reduced populations of specific intestinal bacterial, which suggests that gut dysbiosis may contribute significantly to the development of intense and widespread inflammation [64, 65].